Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.
Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, Oreglia F, Prever L, Manicardi V, Taiana E, Ronchetti D, D'Agostino M, Gay F, Larocca A, Besse L, Merlo GR, Hirsch E, Ciarrocchi A, Inghirami G, Neri A, Piva R. Bandini C, et al. Among authors: larocca a. Exp Hematol Oncol. 2023 Aug 10;12(1):71. doi: 10.1186/s40164-023-00434-x. Exp Hematol Oncol. 2023. PMID: 37563685 Free PMC article.
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.
Rocci A, Gambella M, Aschero S, Baldi I, Trusolino L, Cavallo F, Gay F, Larocca A, Magarotto V, Omedè P, Isaia G, Bertotti A, Liberati AM, Catalano L, De Rosa L, Musto P, Vallone R, Falcone A, Drandi D, Ladetto M, Comoglio PM, Boccadoro M, Palumbo A. Rocci A, et al. Among authors: larocca a. Br J Haematol. 2014 Mar;164(6):841-50. doi: 10.1111/bjh.12719. Epub 2014 Jan 23. Br J Haematol. 2014. PMID: 24450886 Free article.
Nuances in the Management of Older People With Multiple Myeloma.
Pawlyn C, Gay F, Larocca A, Roy V, Ailawadhi S. Pawlyn C, et al. Among authors: larocca a. Curr Hematol Malig Rep. 2016 Jun;11(3):241-51. doi: 10.1007/s11899-016-0323-4. Curr Hematol Malig Rep. 2016. PMID: 27038805 Free article. Review.
Treatment of Newly Diagnosed Elderly Multiple Myeloma.
Fouquet G, Gay F, Boyle E, Bringhen S, Larocca A, Facon T, Leleu X, Palumbo A. Fouquet G, et al. Among authors: larocca a. Cancer Treat Res. 2016;169:123-143. doi: 10.1007/978-3-319-40320-5_8. Cancer Treat Res. 2016. PMID: 27696261 Review.
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.
Gentile M, Magarotto V, Offidani M, Musto P, Bringhen S, Teresa Petrucci M, Gay F, Larocca A, Uccello G, Petrungaro A, Vigna E, Greco R, Grazia Recchia A, Tripepi G, Ria R, Di Raimondo F, Palumbo A, Morabito F. Gentile M, et al. Among authors: larocca a. Am J Hematol. 2017 Mar;92(3):244-250. doi: 10.1002/ajh.24621. Epub 2017 Jan 23. Am J Hematol. 2017. PMID: 28006855 Free article. Clinical Trial.
Novel investigational drugs active as single agents in multiple myeloma.
D'Agostino M, Salvini M, Palumbo A, Larocca A, Gay F. D'Agostino M, et al. Among authors: larocca a. Expert Opin Investig Drugs. 2017 Jun;26(6):699-711. doi: 10.1080/13543784.2017.1324571. Epub 2017 May 8. Expert Opin Investig Drugs. 2017. PMID: 28448171 Free article. Review.
How is patient care for multiple myeloma advancing?
Genadieva Stavric S, Bonello F, Bringhen S, Boccadoro M, Larocca A. Genadieva Stavric S, et al. Among authors: larocca a. Expert Rev Hematol. 2017 Jun;10(6):551-561. doi: 10.1080/17474086.2017.1326814. Epub 2017 May 19. Expert Rev Hematol. 2017. PMID: 28504554 Free article. Review.
Emerging drugs and combinations to treat multiple myeloma.
Larocca A, Mina R, Gay F, Bringhen S, Boccadoro M. Larocca A, et al. Oncotarget. 2017 Jul 15;8(36):60656-60672. doi: 10.18632/oncotarget.19269. eCollection 2017 Sep 1. Oncotarget. 2017. PMID: 28948001 Free PMC article. Review.
175 results